CN Patent

CN101010315A — 用于治疗癌症的取代的吡唑基脲衍生物

Assigned to Bayer Healthcare LLC · Expires 2007-08-01 · 19y expired

What this patent protects

本发明涉及式(I)的化合物、含有它们的药物组合物和用式(I)的化合物治疗癌症的方法。

USPTO Abstract

本发明涉及式(I)的化合物、含有它们的药物组合物和用式(I)的化合物治疗癌症的方法。

Drugs covered by this patent

Xerava (ERAVACYCLINE DIHYDROCHLORIDE) · Tetraphase Pharms

Patent Metadata

Patent number: CN101010315A
Jurisdiction: CN
Classification: —
Expires: 2007-08-01
Drug substance claim: No
Drug product claim: No
Assignee: Bayer Healthcare LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.